MNTA - Momenta Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $6.94. This is a potential upside of $6.94 (0%) from yesterday's end of day stock price of $0.

Momenta Pharmaceuticals's activity chart (see below) currently has 97 price targets and 61 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 96.11% with an average time for these price targets to be met of 264.87 days.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 25-Aug-2020. First documented stock forecast 17-Apr-2015.

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 31-Jan-2017

$50

5 years 4 months 21 days ago
(25-Aug-2020)

11/11 (100%)

$19.95 (66.39%)

190

Hold

Since 24-Aug-2020

$45

5 years 4 months 22 days ago
(24-Aug-2020)

7/7 (100%)

$20.74 (85.49%)

287

Hold

Since 20-Aug-2020

$47

5 years 4 months 26 days ago
(20-Aug-2020)

5/5 (100%)

$18.45 (64.62%)

320

Hold

Since 07-Nov-2018

$38

5 years 4 months 26 days ago
(20-Aug-2020)

3/3 (100%)

$1.53 (4.20%)

124

Hold

Since 19-Aug-2020

$42

$-10.48 (-19.97%)

$42

5 years 4 months 27 days ago
(19-Aug-2020)

3/4 (75%)

$-10.12 (-19.42%)

27

Show more analysts

Please expand the browser size to see the chart

What is MNTA (Momenta Pharmaceuticals) average time for price targets to be met?

On average it took 264.87 days on average for the stock forecasts to be realized with a an average price target met ratio 96.11

Which analyst has the current highest performing score on MNTA (Momenta Pharmaceuticals) with a proven track record?

DANIELLE BRILL

Which analyst has the most public recommendations on MNTA (Momenta Pharmaceuticals)?

Danielle Brill works at TRUIST and has 7 price targets and 7 ratings on MNTA

Which analyst is the currently most bullish on MNTA (Momenta Pharmaceuticals)?

Robyn Karnauskas with highest potential upside - $4.52

Which analyst is the currently most reserved on MNTA (Momenta Pharmaceuticals)?

Dana Flanders with lowest potential downside - -$38.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?